Journal of the American SOCIEty of Regenerative Medicine

Mission Statement, Aims, and Scope

Read the Journal

The Journal of the American Society of Regenerative Medicine (JAARM) is the publication of the American Society of Regenerative Medicine (ASRM). JAARM provides an outlet for quality articles, perspectives, critical reviews, and comments that contribute to the scientific understanding of all aspects of regenerative medicine. JAARM is distinguished by its interdisciplinary nature and breadth, and will provide benefit not only the members of the AARM, but to scientists and clinicians worldwide whose scientific and clinical interests are similar to those of the AARM.

JAARM is a broad-spectrum, open Access, online-only, peer-reviewed journal that considers articles concerned with all aspects of regenerative medicine. Its remit is to publish manuscripts that are regenerative medicine related and that are generally in keeping with the philosophy of American Academy and Board of Regenerative Medicine (AABRM). Such manuscripts may include diagnosis and treatment; basic and clinical research; epidemiology; molecular, cell, and tissue biology; genetics; pathophysiology; epidemiology; tissue and bioengineering; clinical and translational insights; regenerative medicine policies and regulations; ethical issues; and technical or resource-based innovations. We will consider studies from any model that provides insights into regenerative medicine, whether human or veterinary. JAARM will serve, inter alia, as a foundation for scientific and medical advice across the broad spectrum of regenerative medicine. Integrated studies that bridge gaps between traditional scientific and medical disciplines, and economic, social, and public administration studies directly related to regenerative medicine are of importance.

All works to be published in JAARM should demonstrate originality, a non-short-term significance of their underlying message, be of high quality, and present clear indication of their contribution with existing bodies of knowledge. JAARM publishes original articles, brief reports, reviews, and case reports describing novel results of significance in all areas of regenerative medicine.

JAARM will strive for timely consideration and publication of quality material. JAARM will publish all manuscripts deemed of high standard and broad interest, to high technical standards of content, grammar, and style. All material will be given fair consideration if in grammatically acceptable English. JAARM will ensure its editorial staff are of the highest quality and command respect nationally and/or internationally, adapt swiftly to the competitive and changing  environment of scientific publishing while retaining international scientific and medical respect across appropriate scientific and medical disciplines.

Information for Authors

Journal of the American Academy of Regenerative Medicine (JAARM), launched in 2016 by the American Academy of Regenerative Medicine (AARM), publishes research and review articles with a focus on regenerative medicine. Working closely with authors, reviewers, and the scientific editorial board, the editorial staff maintains the high standards of the AARM in its mission to publish timely results of broad interest to the field. Editorial decisions at JAARM are made independently by in-house editorial staff, and JAARM content is freely available online from the time of publication. JAARM follows the guidelines of the Council of Scientific Editors (http://www.councilscienceeditors.org/) and the International Committee of Medical Journal Editors (http://www.icmje.org/).

Editorial Evaluation Timeline

All submissions undergo an initial in-depth evaluation by the scientific editors. If editors deem a submitted paper not a strong candidate for publication, the paper will be returned to the authors without detailed review, typically within 3-5 days. Otherwise, manuscripts will be sent to reviewers who have agreed in advance to assess the paper rapidly. The editors will make every effort to reach decisions on these papers within 3-4 weeks of the submission date. If revisions are a condition of publication, editors will carefully evaluate the reviewers’ comments and, whenever possible, will provide guidance on the important items to be addressed. Generally, we allow 2 months for revisions and consider only one revised version of the paper. Authors are encouraged to make necessary revisions in a timely manner because evaluations of the advancements made by the manuscript and its significance are based on the literature available on the day of the final decision regarding acceptance. Accepted papers will be published online within 1-2 months of acceptance. Any major changes after acceptance are subject to review and may delay publication.

Presubmission Inquiries

If you would like editorial input on whether your paper might be a strong candidate for consideration at JAARM, you can send a presubmission inquiry. The presubmission inquiry should include an abstract, brief description of results, and an explanation of the interest and significance to the broad readership of JAARM. These materials should be emailed to jaarm@aabrm.org. We try to respond to these within 10 days.

Status Inquiries

The online manuscript submission system posts status updates as it progresses through the editorial process. You may also email jaarm@aabrm.org with specific questions.

Authorship

Corresponding Author: The corresponding author(s) is responsible for ensuring that all appropriate contributors are listed as authors and that all authors have agreed to the manuscript’s content and its submission to JAARM. The corresponding author also has the responsibility to ensure that all authors adhere to all the editorial and submission policies. All authorship must be approved in writing by all of the parties. The corresponding author(s) is also responsible for ensuring adherence to all the editorial and submission policies and for any communications and actions that may be necessary after publication. JAARM normally allows for up to two (2) corresponding authors; exceptions will only be considered in cases of compelling need and by prior discussion with the handling editor.

Co-authorship Designations: In recognition of collaborative studies, up to two (2) additional co-senior authors may be designated and will be identified by a numeric footnote in the affiliations list. Beyond co-senior and corresponding author designations (see above), co-authorship designations are only permitted for the first author position. There is no limitation on the number of authors that can be designated as co-first authors, but a description of each author’s specific contribution must be provided in the Author Contributions section of the manuscript. All co-first authors will be identified by a numeric footnote in the affiliations list.

Contributions: As the complexity and interdisciplinary nature of science evolve, so do the network of collaborations both within and between sites. Because the author list in a manuscript can be insufficient for conveying this information, we ask authors to include information about the specific contributions of each author in a dedicated Author Contributions section. More information on authorship can be found at: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

Conflicts of Interest

JAARM requires all authors to disclose any financial conflict of interest that might be construed to influence the results or interpretation of their manuscript. Authors must declare any such conflict in the cover letter accompanying the manuscript. All authors must submit the Conflicts of Interest form of the ICMJE (http://www.icmje.org/conflicts-of-interest/). Additionally, the corresponding author will be asked to sign a form on behalf of all the authors regarding potential conflicts of interest at the time of acceptance. This policy applies to all submitted research manuscripts and review material.

Studies Involving Humans and Animals

The committee that approved the study and confirmation that informed consent was obtained from all subjects must appear in all manuscripts that report studies involving human subjects. Additionally, manuscripts involving experiments on live vertebrates or higher invertebrates must be performed in accordance with relevant institutional and national guidelines and regulations. A statement identifying the committee approving the experiments and confirming that all experiments conformed to the relevant regulatory standards must be included. The editors reserve the right to seek comments from reviewers or additional information from authors on any cases in which concerns arise. It is suggested to consult the Arrive guidelines (http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1000412) and recommendations from an NIH-sponsored workshop (http://www.nature.com/nature/journal/v490/n7419/full/nature11556.html) for designing animal experiments and for reporting on these such experiments.

Data Processing Policy

Every attempt to reduce the amount of post-acquisition data processing should be made. We are aware that there are times when some data processing may be unavoidable and is permitted so long as the final data accurately reflect that of the original data. If data processing involves image processing, than these alterations must be applied to the entire image rather than just sections of the image. There are rare occasions where this may not be possible (e.g., single color channel microscopy); alterations must be clearly stated in the figure legend as well as in the Methods section. In the event that editors and reviewers deem it necessary for proper review of the manuscript, authors will be required to make the original unprocessed data available to the editors and reviewers of the journal.

Chemical Compounds

Authors that submit manuscripts with new chemical entities are required to provide the exact structure of such compounds. Appropriate information should also be submitted to the Cambridge Structural Database (http://www.ccdc.cam.ac.uk/solutions/csd-system/components/csd/) and PubChem (http://pubchem.ncbi.nlm.nih.gov/). The final version of the manuscript submitted to JAARM should include appropriate database identification. Authors submitting manuscripts or either a new chemical entity or a known compound should use systematic nomenclature, based on the guidelines of the International Union of Pure and Applied Chemistry (IUPAC) (http://iupac.org/); use of informal common names (e.g., cholesterol, penicillin) is also acceptable. All abbreviations should be defined at the point where they first occur within the text.

Distributions of Materials and Data

One of the terms and conditions of publishing with JAARM is that authors must be willing to distribute any materials, data sets, and protocols used in published experiments to qualified researchers for their own use.